Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: ESCLEROSE MÚLTIPLA, CÉLULAS-TRONCO (TRANSPLANTE), EXPRESSÃO GÊNICA
ABNT
ARRUDA, L. C. M. et al. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients. Bone Marrow Transplantation, v. 50, n. 3, p. 380-389, 2015Tradução . . Disponível em: https://doi.org/10.1038/bmt.2014.277. Acesso em: 04 nov. 2024.APA
Arruda, L. C. M., Lorenzi, J. C. C., Sousa, A. P. A., Zanette, D. L., Palma, P. V. B., Panepucci, R. A., et al. (2015). Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients. Bone Marrow Transplantation, 50( 3), 380-389. doi:10.1038/bmt.2014.277NLM
Arruda LCM, Lorenzi JCC, Sousa APA, Zanette DL, Palma PVB, Panepucci RA, Brum DS, Barreira AA, Covas DT, Simões BP, Silva Júnior WA da, Oliveira MC, Malmegrim KCR. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients [Internet]. Bone Marrow Transplantation. 2015 ; 50( 3): 380-389.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/bmt.2014.277Vancouver
Arruda LCM, Lorenzi JCC, Sousa APA, Zanette DL, Palma PVB, Panepucci RA, Brum DS, Barreira AA, Covas DT, Simões BP, Silva Júnior WA da, Oliveira MC, Malmegrim KCR. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients [Internet]. Bone Marrow Transplantation. 2015 ; 50( 3): 380-389.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/bmt.2014.277